Pam Fredman
Impact in
- Neurology top 0.5%
- Cell Biology top 1%
- Caveolin-1 and cellular processes
Papers in
- Neurology 36
- Neuroblastoma Research and Treatments 15
- Cell Biology 31
- Caveolin-1 and cellular processes 18
- Co-authors
- Lars SvennerholmJan‐Eric MånssonKaj BlennowJan HolmgrenPia DavidssonKarsten BuschardCamilla HesseBritt‐Marie Rynmark
- Journals
- Journal of Neurochemistry (12 papers)Acta Neurologica Scandinavica (7 papers)European Journal of Biochemistry (5 papers)Dementia and Geriatric Cognitive Disorders (5 papers)Diabetologia (5 papers)
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Pam Fredman
175 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Neurology 1.4k
- Cell Biology 1.1k
- Physiology 1.7k
- Immunology 1.4k
- Molecular Biology 4.3k
Countries citing papers authored by Pam Fredman
This map shows the geographic impact of Pam Fredman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pam Fredman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pam Fredman more than expected).
Fields of papers citing papers by Pam Fredman
This network shows the impact of papers produced by Pam Fredman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pam Fredman. The network helps show where Pam Fredman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pam Fredman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 18 | |
| 2 | 2009 | 10 | |
| 3 | 2006 | 13 | |
| 4 | 2003 | 24 | |
| 5 | 2003 | 13 | |
| 6 | 2002 | 16 | |
| 7 | 2000 | 29 | |
| 8 | 1999 | 26 | |
| 9 | 1999 | 19 | |
| 10 | 1998 | 24 | |
| 11 | 1997 | 19 | |
| 12 | 1997 | 12 | |
| 13 | 1996 | 7 | |
| 14 | 1996 | 42 | |
| 15 | 1994 | 1 | |
| 16 | 1994 | 41 | |
| 17 | 1993 | 146 | |
| 18 | 1992 | 13 | |
| 19 | 1990 | 36 | |
| 20 | 1989 | 26 |
About Pam Fredman
Pam Fredman is a scholar working on Neurology, Cell Biology, Immunology, Molecular Biology and Virology, having authored 177 papers that have together received 8.0k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (88 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), Pancreatic function and diabetes (20 papers), Galectins and Cancer Biology (20 papers), Diabetes and associated disorders (19 papers), Caveolin-1 and cellular processes (18 papers), Neuroblastoma Research and Treatments (15 papers) and Alzheimer's disease research and treatments (15 papers). The work is most often cited by research in Neurology (1.4k citations), Cell Biology (1.1k citations), Physiology (1.7k citations), Immunology (1.4k citations) and Molecular Biology (4.3k citations). Pam Fredman has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Lars Svennerholm, Jan‐Eric Månsson, Kaj Blennow, Jan Holmgren, Pia Davidsson, Karsten Buschard, Camilla Hesse, Britt‐Marie Rynmark, Carsten Wikkelsø and Kerstin Boström. Their work appears in journals such as Journal of Neurochemistry, Acta Neurologica Scandinavica, European Journal of Biochemistry, Dementia and Geriatric Cognitive Disorders and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.